OMOP Concept 1145484
sacituzumab
StandardDrugRxNorm2360231Ingredient
Maps from
16
Descendants
22
Valid from
3 Aug 2020
Valid to
31 Dec 2099
OMOP concepts
Concept Lookup Tool
Search 11M+ concepts across SNOMED, RxNorm, ICD-10 & LOINC.
Source codes that map to this concept
16 source codes normalize to sacituzumab via the OMOP "Maps to" relationship.
| Vocabulary | Code | Name | Type |
|---|---|---|---|
| ATC | L01FX17 | sacituzumab govitecan | Classification |
| CIEL | 167615 | Sacituzumab govitecan | Non-standard |
| dm+d | 871701001 | Sacituzumab govitecan | Non-standard |
| HemOnc | 456 | Sacituzumab govitecan | Non-standard |
| OMOP Invest Drug | 73H2I6QS54 | SACITUZUMAB | Non-standard |
| OMOP Invest Drug | M9BYU8XDQ6 | SACITUZUMAB GOVITECAN | Non-standard |
| RxNorm | 2360232 | sacituzumab govitecan | Non-standard |
| RxNorm | 2360530 | sacituzumab govitecan-hziy | Non-standard |
| SNOMED | 871700000 | Sacituzumab | Non-standard |
| SNOMED | 871701001 | Sacituzumab govitecan | Non-standard |
| SNOMED | 871812009 | Sacituzumab govitecan-containing product | Non-standard |
| SNOMED | 871813004 | Sacituzumab govitecan only product | Non-standard |
| SNOMED | 871814005 | Sacituzumab govitecan-containing product in parenteral dose form | Non-standard |
| SNOMED | 871815006 | Sacituzumab govitecan only product in parenteral dose form | Non-standard |
| VANDF | 4039353 | SACITUZUMAB GOVITECAN-HZIY | Non-standard |
| VANDF | 4039354 | SACITUZUMAB GOVITECAN | Non-standard |
Where it sits in the hierarchy
Ordered by distance - 1 is a direct parent or child.
Broader concepts
(12)Roll up to these when you need a wider cohort.
- 1Antibody-drug conjugate
- 1Anti-TACSTD2 antibody
- 1Other monoclonal antibodies and antibody drug conjugates
- 1Topoisomerase inhibitor
- 2Antineoplastic monoclonal antibody
- 2MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES
- 3Antibody medication
- 3ANTINEOPLASTIC AGENTS
- 3Cytotoxic chemotherapeutic
- 4ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
- 4Targeted therapeutic
- 5Antineoplastics by class effect
Narrower concepts
(22)Included automatically when you query with descendants.
- 1sacituzumab govitecan-hziy 180 MG
- 1sacituzumab govitecan-hziy 180 MG [Trodelvy]
- 1Sacituzumab govitecan monotherapy
- 1sacituzumab Injectable Product
- 1sacituzumab Injectable Solution
- 1sacituzumab Injectable Solution [Trodelvy]
- 1sacituzumab Injection
- 1sacituzumab Injection [Trodelvy]
- 1Trodelvy Injectable Product
- 2sacituzumab 180 MG Injectable Solution
- 2sacituzumab 180 MG Injectable Solution [Trodelvy]
- 2sacituzumab 180 MG Injection [Trodelvy]
- 2sacituzumab govitecan-hziy 180 MG Injection
- 2sacituzumab govitecan-hziy 180 MG Injection [Trodelvy]
- 3sacituzumab 180 MG Injectable Solution Box of 1
- 3sacituzumab 180 MG Injectable Solution [Trodelvy] Box of 1
- 3sacituzumab 180 MG Injectable Solution [Trodelvy] Box of 1 by Gilead
- 3sacituzumab 180 MG Injectable Solution [Trodelvy] by Gilead
- 3sacituzumab 180 MG Injection Box of 1
- 3sacituzumab 180 MG Injection [Trodelvy] Box of 1
- 3sacituzumab 180 MG Injection [Trodelvy] Box of 1 by Gilead
- 3sacituzumab 180 MG Injection [Trodelvy] by Gilead
Get this concept via the API
Resolve sacituzumab - and every code that maps to it - over HTTPS, against the current vocabulary release. No downloads, no local database.
curl "https://api.omophub.com/v1/concepts/1145484?include_relationships=true" \
-H "Authorization: Bearer $OMOPHUB_API_KEY"Get your free API key3,000 calls/month free · no credit card